Please login to the form below

Not currently logged in

HBV vaccine prevents liver cancer

Research demonstrates protection offered by vaccination programme

A paper published in Journal of the National Cancer Institute has indicated that babies vaccinated against hepatitis B have significantly reduced incidence of liver cancer in later life.

Researchers in Taiwan followed up babies vaccinated as part of a universal hepatitis B virus vaccination programme launched in July 1984. Of 1,958 patients, aged 6–29 years, diagnosed with cancer of the liver (hepatocellular carcinoma) they found only 64 cases in the vaccinated group compared with 444 in the unvaccinated birth cohorts.

Hepatitis B virus (HBV) is a major cause of liver cancer and children generally contract it from their mothers. The virus can also be transmitted by sex, intravenous drug use or blood transfusion.

22nd September 2009


Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...